U.S. Hospitality Stock News

NasdaqGS:ENTG
NasdaqGS:ENTGSemiconductor

Entegris (ENTG) Stock After Cross Licensing Deal With JSR Is The Recent Rally Now Overvalued

Entegris (ENTG) has drawn fresh attention after announcing a cross licensing agreement with JSR and Inpria that ends a patent dispute and sets up cooperation on EUV photoresist and filtration technology for advanced chips. See our latest analysis for Entegris. The cross licensing deal has arrived on the back of strong momentum, with Entegris delivering a 90 day share price return of 40.24% and a 1 year total shareholder return of 108.81%. This suggests that investors are increasingly willing...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Should Zscaler’s AI-Driven Zero Trust Expansion Amid Index Exit Require Action From ZS Investors?

Zscaler recently expanded its Zero Trust SASE platform with new AI- and agent-focused capabilities and announced integrations with Oasis Security, Radiant Logic, and Gigamon to strengthen identity governance and observability across complex hybrid environments. These moves deepen Zscaler’s role at the center of zero trust and AI security architectures, even as the company faces index removal, leadership turnover, and legal scrutiny that raise questions about its execution and...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health (CLOV) Is Up 20.7% After Court-Ordered Medicare Star Rating Upgrade - What's Changed

Clover Health Investments recently won a U.S. District Court case that led CMS to recalculate and upgrade its 2026 Medicare Star Rating for the company’s PPO plan from 3.5 to 4.5 stars, which is expected to influence payment year 2027 bonuses and reimbursement levels. This court-ordered rating improvement not only supports higher-quality perceptions of Clover Health’s Medicare Advantage offering, but also reshapes the financial importance of its technology-enabled care model within the...
NYSE:TR
NYSE:TRFood

Did Mr. Owl’s New Multi-Flavor Role Just Shift Tootsie Roll Industries’ (TR) Investment Narrative?

Tootsie Roll Industries recently debuted a new Mr. Owl TV spot that introduces a color-changing chameleon, highlights multiple Tootsie Roll flavors, and extends the refreshed “How Many Licks” concept across connected TV and major social platforms, while continuing the character’s whimsical charm. An interesting shift in brand storytelling is that, for the first time, Mr. Owl is shown enjoying a Tootsie Roll instead of his traditional Tootsie Pop, signaling an effort to broaden his role...
NasdaqGS:BZ
NasdaqGS:BZProfessional Services

How Investors Are Reacting To Kanzhun (BZ) Surging Users, Rising Revenue Guidance and Aggressive Buybacks

Kanzhun Ltd recently reported past-quarter operating metrics showing over 15 million newly verified users and 7.1 million paid enterprise customers, alongside guidance for Q2 2026 revenue implying a 13.2% to 15.1% year-on-year increase. The company also highlighted more than US$200,000,000 of share repurchases this year, underlining management’s commitment to returning capital to shareholders. Next, we’ll examine how the strong growth in paid enterprise customers might reshape Kanzhun’s...
NasdaqGS:MAT
NasdaqGS:MATLeisure

Is Mattel’s Barbie Dunkin’ Tie-Up Deepening Its Lifestyle Brand Strategy For Mattel (MAT)?

Earlier this month, Dunkin’ announced a collaboration with Mattel’s Barbie brand, adding a limited-time Barbie Pink Strawberry Cold Foam topper across a new lineup of pink, fruit-forward iced beverages and themed menu items in the US. This tie-up extends Barbie’s reach into everyday food-and-drink occasions, reinforcing the brand’s cultural visibility through an experiential, co-branded offering with a major coffee chain. Next, we’ll examine how this Barbie-themed Dunkin’ beverage lineup...
NYSE:GL
NYSE:GLInsurance

Globe Life (GL) Stock After Mad Money Praise And Analyst Upgrades Is The Valuation Gap Still There

Fresh attention on Globe Life after media spotlight Globe Life (GL) moved onto more investors' radar after favorable comments on Mad Money highlighted its value profile and defensive role, coinciding with analyst momentum signals and upward revisions to earnings estimates. See our latest analysis for Globe Life. Those comments have landed on a stock already enjoying positive momentum, with a 7 day share price return of 6.13% and a 90 day share price return of 19.37%, while the 1 year total...
NYSE:UTZ
NYSE:UTZFood

Utz Brands (UTZ) Stock Valuation Check After A Difficult Year Of Share Price Declines

Recent performance snapshot Utz Brands (UTZ) shares closed at $7.14, with the stock down about 31% year to date and around 45% over the past year. This performance is keeping investor attention on its fundamentals. See our latest analysis for Utz Brands. Short term trading has been slightly positive, with the 7 day share price return of 3.48% and 30 day share price return of 1.42%. However, this follows a much weaker patch where the 90 day share price return declined 6.18% and the 1 year...
NasdaqCM:IMNM
NasdaqCM:IMNMBiotechs

How Immunome’s First-in-Human IM-1617 ADC Trial At Immunome (IMNM) Has Changed Its Investment Story

Immunome, Inc. recently dosed the first patient in a Phase 1, first-in-human trial of IM-1617, a potential first-in-class antibody-drug conjugate using its proprietary HC74 TOP1 inhibitor payload in advanced solid tumors such as colorectal, non-small cell lung, and breast cancer. This trial not only marks Immunome’s initial entry into human testing for its solid tumor ADC platform but also highlights progress toward a broader ADC pipeline, with investigational new drug submissions for...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

MercadoLibre (MELI) Stock Valuation After US$4.6b Expansion Plan In Mexico

Why MercadoLibre (MELI) is back on investors' radar MercadoLibre (MELI) is drawing fresh attention after being highlighted as undervalued based on cash flows, just as it commits US$4.6b to expand logistics, technology, and financial services in Mexico. See our latest analysis for MercadoLibre. Despite being picked out as undervalued based on cash flows and announcing a US$4.6b push into Mexico, MercadoLibre’s share price has been under pressure. The stock is down 19.46% year to date and the 1...
NasdaqGS:FFIN
NasdaqGS:FFINBanks

How Dividend Growth And Yield At First Financial Bankshares (FFIN) Has Changed Its Investment Story

Recent commentary on First Financial Bankshares highlighted its status as a dividend payer, with a 2.28% yield and four dividend increases over the past five years. An interesting detail for income-focused investors is the company’s average annualized dividend growth of 7.93% in five years, supported by expectations for higher earnings in 2026. Next, we’ll examine how this combination of above-peer dividend yield and anticipated earnings growth could influence First Financial Bankshares’...
NYSE:ARLO
NYSE:ARLOElectronic

Arlo Technologies (ARLO) Stock After Earnings Beat And Selloff Is The Valuation Gap Justified

Arlo Technologies (ARLO) just reported quarterly revenue of US$150.4 million, 26.3% higher year on year and ahead of published estimates, yet the stock fell sharply as investors reacted to softer sentiment signals. See our latest analysis for Arlo Technologies. At a share price of US$12.92, Arlo’s recent 1 month share price return of 4.87% comes after a 3 month period where the share price fell 8.30%. Over 1 year, the total shareholder return is down 25.01%, while the 5 year total shareholder...
NYSE:TFC
NYSE:TFCBanks

Truist Financial (TFC) Stock Valuation After New CEO Appointment And Commercial Real Estate Expansion

Leadership shift and real estate expansion put Truist in focus Truist Financial (TFC) is back on investors' radar after naming seasoned banking executive Michael P. Lyons as its next CEO and president, alongside a push into expanded commercial real estate servicing. See our latest analysis for Truist Financial. The CEO succession news and commercial real estate expansion arrive while momentum in Truist's shares has been building, with a 30 day share price return of 10.01% and a 1 year total...
NYSE:AWK
NYSE:AWKWater Utilities

Do Recent Rate Wins And Upgrades Change The Bull Case For American Water Works Company (AWK)?

In recent weeks, American Water Works Company has secured revenue-supportive rate agreements in California and Virginia, completed a major main replacement project, and expanded its community and workforce development programs across multiple states. Taken together, these regulatory wins, infrastructure upgrades, and community investments highlight how the company is reinforcing its regulated revenue base and long-term operating resilience. Next, we’ll examine how these favorable rate...
NYSE:CXT
NYSE:CXTElectronic

Crane NXT (CXT) Stock Valuation After Sector Rally And Easing Geopolitical Risk

Crane NXT (CXT) has been in focus after a strong sector wide rally in specialty industrial machinery stocks, alongside improving macro signals such as lower perceived geopolitical risk and renewed confidence in corporate spending plans. See our latest analysis for Crane NXT. Short term momentum has picked up, with a 1 day share price return of 3.56% and 7 day share price return of 15.88%, but the 1 year total shareholder return is still down 23.88%. Recent strength is therefore working...
NasdaqCM:NN
NasdaqCM:NNSoftware

How NextNav’s Drone Airspace Standards Push (NN) Has Changed Its Investment Story

In June 2026, NextNav Inc. announced it had joined GSMA and cross-industry partners in an industry-first call to action to define how mobile networks, secure positioning, and resilient connectivity can support safer, scalable drone airspace operations. This collaboration places NextNav at the center of emerging standards for trusted low-altitude aviation, where secure geolocation and multi-layer connectivity are becoming critical infrastructure for future drone and eVTOL use cases. We'll now...
NYSE:AMT
NYSE:AMTSpecialized REITs

Did American Tower’s (AMT) Note Redemption and Rating Upgrade Just Reframe Its 5G Infrastructure Story?

Earlier this month, American Tower Corporation announced plans to redeem US$250,000,000 of its US$600,000,000 4.125% senior unsecured notes due 2027 on June 18, 2026, while Bernstein raised its analyst rating on the company to Outperform based on long-term 5G and data center demand. Bernstein’s upgrade underscores confidence in American Tower’s extensive tower portfolio, long-term lease profile, and the continued need for ground-based infrastructure alongside emerging satellite services. We...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

VEON (NasdaqGS:VEON) Stock And The Value Question After Its Recent Digital Expansion Moves

VEON (VEON) is in focus after three recent moves, including World Cup 2026 streaming rights for Banglalink’s Toffee platform, the Uklon Store launch in Ukraine, and the appointment of a new Chief of Staff and Strategy Officer. See our latest analysis for VEON. These digital moves arrive as VEON’s share price sits at US$52.42, with a 1 day share price return of 3.82% and a 90 day share price return of 6.87%. The 1 year total shareholder return of 31.02% and 3 year total shareholder return of...
NYSE:ATKR
NYSE:ATKRElectrical

Atkore (ATKR) Stock After US$50 Million Settlement What Does The Valuation Now Signal

Settlement gives Atkore investors fresh context Atkore (ATKR) has agreed to a US$50 million settlement with the third putative class in the PVC Pipe Antitrust Litigation, subject to court approval. The agreement aims to resolve End User Plaintiff claims and reduce legal uncertainty. See our latest analysis for Atkore. Atkore’s US$79.27 share price follows a 41.2% 3 month share price return and a 23.03% year to date share price return, while the 3 year total shareholder return is down 40.98%...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Walmart (WMT) Stock Valuation Split Between Community Optimism And Cash Flow Caution

How Walmart stock has been trading recently Walmart (WMT) has attracted fresh attention after a mixed stretch in the share price, with the stock up slightly in the past week but down over the past month and past 3 months. See our latest analysis for Walmart. That recent pullback, with a 30 day share price return of down 7.9% and a 90 day share price return of down 3.2%, sits against a much stronger backdrop. The year to date share price return is 7.3% and the 1 year total shareholder return...
NYSE:RLJ
NYSE:RLJHotel and Resort REITs

Is RLJ Lodging Trust’s Latest Dividend Move Sharpening Its Capital Allocation Story (RLJ)?

RLJ Lodging Trust’s Board of Trustees has declared a past quarterly cash dividend of $0.15 per common share for the second quarter of 2026, payable on July 15, 2026, to shareholders of record as of June 30, 2026, alongside a $0.4875 Series A preferred dividend payable on July 31, 2026. These continued common and preferred dividend payments, coming after stronger earnings and debt refinancing progress, highlight management’s emphasis on returning cash to investors while maintaining capital...
NYSE:WMK
NYSE:WMKConsumer Retailing

Did Instacart’s AI Caper Carts Just Reframe Weis Markets’ (WMK) In‑Store Data Advantage?

In early June 2026, Instacart announced it had launched its AI-powered Caper Carts at select Weis Markets stores in Pennsylvania, with further rollouts planned this year to bring real-time spend tracking, personalized digital coupons, and on-cart loyalty integration to shoppers. This expansion also gives Weis a new retail media channel through on-cart advertising and location-aware prompts that can influence basket size and product discovery in-store. We’ll now examine how introducing...
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

COMP360’s Phase 3 Success and FDA Filing Could Be A Game Changer For COMPASS Pathways (CMPS)

Earlier this year, COMPASS Pathways reported that its lead therapy, COMP360, achieved statistically significant reductions in depressive symptoms in a Phase 3 program and advanced a rolling FDA New Drug Application, materially lowering regulatory uncertainty around its first potential product. This progress marks a shift from pure clinical research toward building a commercial-scale mental health platform, which could make COMPASS Pathways more interesting to larger pharmaceutical companies...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Why Precigen (PGEN) Is Up 24.6% After FDA Orphan Exclusivity Win For PAPZIMEOS

In recent days, Precigen announced that the FDA has granted orphan drug exclusivity to PAPZIMEOS for recurrent respiratory papillomatosis (RRP), following long‑term data showing durable responses in patients treated with this HPV‑targeted immunotherapy. The new exclusivity, combined with multi‑year response durability data presented at ASCO, strengthens PAPZIMEOS’s position as a potential standard of care in this rare disease. We’ll now examine how orphan drug exclusivity for PAPZIMEOS could...